glp-1 news today pharma Drugs: The Science and the Scarcity biotech news today glp-1 Therapies

The newer Wegovy 7.2 mg dose achieves 20.7%, a difference of around 1 to 2 percentage points

Manning MC, et al

Overview of radiolabeled somatostatin analogs for cancer imaging and therapy

NEJM 380, 752762

Exciting times, but careful evaluation of long-term safety, real-world outcomes, and patient access will be key From a neurological perspective, this overview is helpful, but what may become even more important is understanding how hormonal status shapes metabolic response

From restoring blood flow and performance to revitalizing desire through Hormone Optimization, our expert treatments address the root cause to help you reclaim your passion and live with total Vitality